Back
BeiGene 10K Form
Sell
32
BGNE
BeiGene
Last Price:
162.50
Seasonality Move:
3.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BGNE News And Ratings
See the #1 stock for the next 7 days that we like better than BGNE
BGNE Financial Statistics
Sales & Book Value
| Annual Sales: | $2.46B |
|---|---|
| Cash Flow: | $-501.62M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $32.16 |
| Price / Book: | 5.14 |
Profitability
| EPS (TTM): | -7.67000 |
|---|---|
| Net Income (TTM): | $-784.43M |
| Gross Margin: | $2.08B |
| Return on Equity: | -21.07% |
| Return on Assets: | -13.67% |
BeiGene Earnings Forecast
Key BeiGene Financial Ratios
- The Gross Profit Margin over the past 11 years for BGNE is 84.55%.
- The Selling, General & Administrative Expenses for BGNE have been equal to 61.19% of Gross Profit Margin.
- The Research & Development expenses have been 72.34% of Revenue.
- The Interest Expense is -42.19% of Operating Income.
- The Net Earning history of BGNE is -35.86% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 3 years.
BeiGene Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BGNE |
| CUSIP: | 07725L |
| Website: | beigene.com |
Debt
| Debt-to-Equity Ratio: | 0.31 |
|---|---|
| Current Ratio: | 2.08 |
| Quick Ratio: | 1.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |